Next Biomedical Co., Ltd.
Clinical trials sponsored by Next Biomedical Co., Ltd., explained in plain language.
Next Biomedical Co., Ltd.
389650
KOSDAQ
Biomedical company focused on medical devices and diagnostics.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New embolization treatment aims to ease knee pain without surgery Results expected Feb 2027 (estimated)